BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 18464110)

  • 1. Hodgkin lymphoma in very young children: Clinical characteristics and outcome of treatment.
    Belgaumi A; Al-Kofide A; Joseph N; Jamil-Malik R; Khafaga Y; Sabbah R
    Leuk Lymphoma; 2008 May; 49(5):910-6. PubMed ID: 18464110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hodgkin lymphoma in children, adolescents and young adults - a comparative study of clinical presentation and treatment outcome.
    Englund A; Glimelius I; Rostgaard K; Smedby KE; Eloranta S; Molin D; Kuusk T; Brown PN; Kamper P; Hjalgrim H; Ljungman G; Hjalgrim LL
    Acta Oncol; 2018 Feb; 57(2):276-282. PubMed ID: 28760045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics and outcome of pediatric patients with stage IV Hodgkin lymphoma.
    Belgaumi A; Al-Kofide AA; Khafaga Y; Joseph N; Jamil-Malik R; Siddiqui KS; Sabbah RS
    Hematol Oncol Stem Cell Ther; 2009; 2(1):278-84. PubMed ID: 20063558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hodgkin lymphoma in Tyrol-a population-based study.
    Fong D; Steurer M; Greil R; Gunsilius E; Spizzo G; Gastl G; Tzankov A
    Ann Hematol; 2009 May; 88(5):449-56. PubMed ID: 18846373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome and prognostic factors of pediatric patients with Hodgkin lymphoma: a single-center experience.
    Ali N; Mansour M; Khalil E; Ebeid E
    J Egypt Natl Canc Inst; 2023 Sep; 35(1):29. PubMed ID: 37691044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma].
    Niu Y; Shi YK; He XH; Feng FY; Zhou LQ; Gu DZ
    Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):630-4. PubMed ID: 19102946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcome of treatment for Hodgkin's disease: the University Hospital Sofia experience.
    Gocheva L; Koleva I
    Klin Onkol; 2010; 23(1):34-42. PubMed ID: 20192072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Childhood Hodgkin International Prognostic Score (CHIPS) Predicts event-free survival in Hodgkin Lymphoma: A Report from the Children's Oncology Group.
    Schwartz CL; Chen L; McCarten K; Wolden S; Constine LS; Hutchison RE; de Alarcon PA; Keller FG; Kelly KM; Trippet TA; Voss SD; Friedman DL
    Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 27786406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors predicting outcomes for primary refractory hodgkin lymphoma patients treated with salvage chemotherapy and autologous stem cell transplantation.
    Shah GL; Yahalom J; Matasar MJ; Verwys SL; Goldman DA; Bantilan KS; Zhang Z; McCall SJ; Moskowitz AJ; Moskowitz CH
    Br J Haematol; 2016 Nov; 175(3):440-447. PubMed ID: 27377168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors and treatment outcome in childhood Hodgkin disease.
    Oguz A; Karadeniz C; Okur FV; Citak EC; Pinarli FG; Bora H; Akyurek N
    Pediatr Blood Cancer; 2005 Oct; 45(5):670-5. PubMed ID: 16007600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical characteristics of 34 children with Hodgkin lymphoma and efficacy of treatment with chemotherapy plus low dose radiotherapy on involved sites].
    Duan YL; Zhang YH; Jin L; Yang J; Zhang R; Zhou CJ
    Zhonghua Er Ke Za Zhi; 2010 Sep; 48(9):698-702. PubMed ID: 21092533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of involved-field radiotherapy to survival in patients with relapsed or refractory Hodgkin lymphoma undergoing autologous stem cell transplantation.
    Eroglu C; Kaynar L; Orhan O; Keklik M; Sahin C; Yildiz OG; Mentes S; Kurnaz F; Aslan D; Sivgin S; Soyuer S; Eser B; Cetin M; Unal A
    Am J Clin Oncol; 2015 Feb; 38(1):68-73. PubMed ID: 23563207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The treatment of childhood Hodgkin lymphoma: improved survival in a developing country.
    Büyükpamukçu M; Varan A; Akyüz C; Atahan L; Ozyar E; Kale G; Köksal Y; Kutluk T
    Acta Oncol; 2009; 48(1):44-51. PubMed ID: 18777215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized study of intensive MOPP-ABVD with or without low-dose total-nodal radiation therapy in the treatment of stages IIB, IIIA2, IIIB, and IV Hodgkin's disease in pediatric patients: a Pediatric Oncology Group study.
    Weiner MA; Leventhal B; Brecher ML; Marcus RB; Cantor A; Gieser PW; Ternberg JL; Behm FG; Wharam MD; Chauvenet AR
    J Clin Oncol; 1997 Aug; 15(8):2769-79. PubMed ID: 9256118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved survival in patients with limited stage IIIA Hodgkin's disease treated with combined radiation therapy and chemotherapy.
    Marcus KC; Kalish LA; Coleman CN; Shulman LN; Rosenthal DS; Canellos GP; Mauch PM
    J Clin Oncol; 1994 Dec; 12(12):2567-72. PubMed ID: 7989930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Young adults diagnosed with Hodgkin lymphoma are at risk of relapsing late: a comprehensive analysis of late relapse in Hodgkin lymphoma.
    Pinczés L; Miltényi Z; Illés Á
    J Cancer Res Clin Oncol; 2018 May; 144(5):935-943. PubMed ID: 29468437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of pediatric Hodgkin disease avoiding radiotherapy: excellent outcome with the Rotterdam-HD-84-protocol.
    Hakvoort-Cammel FG; Buitendijk S; van den Heuvel-Eibrink M; Hählen K
    Pediatr Blood Cancer; 2004 Jul; 43(1):8-16. PubMed ID: 15170884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary refractory Hodgkin's lymphoma: outcome after high-dose chemotherapy and autologous SCT and impact of various prognostic factors on overall and event-free survival. A single institution result of 66 patients.
    Akhtar S; El Weshi A; Abdelsalam M; Hussaini H; Janabi I; Rahal M; Maghfoor I
    Bone Marrow Transplant; 2007 Oct; 40(7):651-8. PubMed ID: 17660837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome analysis of high-dose chemotherapy and autologous stem cell transplantation in adolescent and young adults with relapsed or refractory Hodgkin lymphoma.
    Akhtar S; Rauf SM; Elhassan TA; Maghfoor I
    Ann Hematol; 2016 Sep; 95(9):1521-35. PubMed ID: 27376363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Early-Stage Unfavorable Hodgkin Lymphoma: Efficacy and Toxicity of 4 Versus 6 Cycles of ABVD Chemotherapy With Radiation.
    Gunther JR; Fanale MA; Reddy JP; Akhtari M; Smith GL; Pinnix CC; Milgrom SA; Yehia ZA; Allen PK; Osborne EM; Mawlawi O; Dabaja BS
    Int J Radiat Oncol Biol Phys; 2016 Sep; 96(1):110-8. PubMed ID: 27325479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.